McKesson Corporation (MCK)

NYSE: MCK · IEX Real-Time Price · USD
321.55
+6.89 (2.19%)
At close: Jun 24, 2022 4:04 PM
326.50
+4.95 (1.54%)
After-hours: Jun 24, 2022 7:57 PM EDT

Company Description

McKesson Corporation provides healthcare services in the United States and internationally.

It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.

This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies.

The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers.

The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions.

McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

McKesson Corporation
McKesson Logo
Country United States
Founded 1833
Industry Health Care Providers & Services
Sector Health Care
Employees 58,000
CEO Brian Tyler

Contact Details

Address:
6555 State Highway 161
Irving, Texas 75039-2402
United States
Phone 972 446 4800
Website mckesson.com

Stock Details

Ticker Symbol MCK
Exchange NYSE
Fiscal Year April - March
Reporting Currency US Dollars
CIK Code 0000927653

Key Executives

Name Position
Brian S. Tyler Ph.D. Chief Executive Officer and Director
Britt J. Vitalone Executive Vice President and Chief Financial Officer
Nancy Flores Executive Vice President, Chief Information Officer and Chief Technology Officer
Lori A. Schechter J.D. Executive Vice President, Chief Legal Officer and General Counsel
Tracy L. Faber Executive Vice President and Chief Human Resources Officer
Napoleon B. Rutledge Jr. Senior Vice President, Controller and Chief Accounting Officer
Holly Weiss Senior Vice President of Investor Relations
Pete Slone Senior Vice President of Corporate Public Affairs
Kirk Kaminsky President of The US Pharmaceutical and Specialty Solutions Business
Paul A. Smith Senior Vice President of Taxes

Latest SEC Filings

Date Type Title
Jun 22, 2022 4 Statement of changes in beneficial ownership of securities
Jun 17, 2022 4 Statement of changes in beneficial ownership of securities
Jun 14, 2022 4 Statement of changes in beneficial ownership of securities
Jun 9, 2022 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 9, 2022 DEF 14A Other definitive proxy statements
Jun 7, 2022 4 Statement of changes in beneficial ownership of securities
Jun 7, 2022 4 Statement of changes in beneficial ownership of securities
Jun 1, 2022 4 Statement of changes in beneficial ownership of securities
Jun 1, 2022 4 Statement of changes in beneficial ownership of securities
Jun 1, 2022 4 Statement of changes in beneficial ownership of securities